Talphera Newsroom

Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsNov 16 10:31 ET

Talphera's Promising Prospects: Buy Rating Affirmed Amidst Strategic Advancements in Anticoagulant Development

TipRanksNov 16 09:57 ET

H.C. Wainwright Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsNov 14 12:31 ET

Optimistic Buy Rating for Talphera Driven by Promising NEPHRO CRRT Study Progress and Niyad's Potential

TipRanksNov 14 12:20 ET

Maxim Group Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $3

Moomoo NewsAug 16 07:35 ET

Bullish Outlook on Talphera's Niyad: Phase 3 Trial Advancements and Market Potential Justify Buy Rating

TipRanksAug 16 07:27 ET

Talphera Analyst Ratings

BenzingaAug 16 05:46 ET

A. G. P. Initiates Talphera(TLPH.US) With Buy Rating, Announces Target Price $3.5

Moomoo NewsAug 15 20:31 ET

H.C. Wainwright Maintains Talphera(TLPH.US) With Buy Rating, Maintains Target Price $6

Moomoo NewsAug 15 12:32 ET

Buy Rating Affirmed for Talphera Amid Strategic Advancements in NEPHRO CRRT Study

TipRanksAug 15 11:37 ET

Optimistic Buy Rating for Talphera Despite Phase 3 Trial Enrollment Delay

TipRanksMay 16 10:55 ET

Talphera Analyst Ratings

BenzingaMay 15 10:52 ET

Analysts Are Bullish on These Healthcare Stocks: Talphera (TLPH), NexGel Inc (NXGL)

TipRanksMay 15 07:40 ET

Talphera Analyst Ratings

BenzingaMay 6 09:13 ET

Talphera Analyst Ratings

BenzingaMar 7 07:14 ET

HC Wainwright & Co. Reiterates Buy on Talphera, Maintains $6 Price Target

BenzingaMar 7 07:13 ET

Talphera Analyst Ratings

BenzingaJan 22 13:04 ET

Talphera's Strategic Rebrand and Niyad's Market Potential Bolster Buy Rating

TipRanksJan 10 06:26 ET

HC Wainwright & Co. Reiterates Buy on AcelRx Pharmaceuticals, Maintains $5 Price Target

BenzingaDec 7, 2023 06:45 ET

AcelRx Pharmaceuticals Analyst Ratings

BenzingaDec 7, 2023 06:44 ET